2 results
Approved WMOCompleted
This clinical trial is being performed to evaluate the PK profile of TBS-2 administered as single and multiple (BID) doses in patients with HSDD or ANOR. In addition, the study will evaluate the initial PD efficacy and safety of intranasal TBS-2 BID…
Approved WMOPending
To date, no dedicated prospective, randomized, blinded trials have been performed to assess the benefit of CRT in patients with NICD. It is difficult to hypothesize whether CRT implantation may be beneficial in patients with NICD. The objective of…